PFG Investments’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.8K Buy
19,000
+5,500
+41% +$16.4K ﹤0.01% 1256
2026
Q1
$41.6K Buy
+13,500
New +$57.3K ﹤0.01% 1163
2025
Q3
– Sell
-12,000
Closed -$46.4K – 1113
2025
Q2
$46.4K Sell
12,000
-5,500
-31% -$29.8K ﹤0.01% 1006
2025
Q1
$87.5K Buy
17,500
+4,200
+32% +$26.6K 0.01% 947
2024
Q4
$95.9K Buy
+13,300
New +$102K 0.01% 953
2024
Q3
– Sell
-10,100
Closed -$67.2K – 1023
2024
Q2
$67.2K Buy
+10,100
New +$74.5K ﹤0.01% 886

Other funds holding ALT

PFG Investments's ALT Position: Q2 2026 in Review

PFG Investments increased its Altimmune (ALT) stake by 41% in Q2 2026, buying an estimated $16.4K and bringing the position to 19,000 shares worth $57.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

PFG Investments first reported a position in ALT in Q2 2024 and has held it in 6 quarters since. The position peaked at $95.9K in Q4 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • PFG Investments held 19,000 shares of Altimmune worth $57.8K as of Q2 2026.
  • PFG Investments bought 5,500 Altimmune shares in Q2 2026, an estimated $16.4K.
  • Altimmune made up ﹤0.01% of PFG Investments's portfolio in Q2 2026, its #1256 holding.
  • PFG Investments first reported a position in Altimmune in Q2 2024 and has held it in 6 quarters since.
  • PFG Investments's Altimmune position peaked at $95.9K in Q4 2024.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.